Cæcilie Bachdal Johansen, Alexander Egeberg, Espen Jimenez-Solem, Lone Skov, Simon Francis Thomsen
Issues - Giugno 2022
Cæcilie Bachdal Johansen, Alexander Egeberg, Espen Jimenez-Solem, Lone Skov, Simon Francis Thomsen
Wafaa A. Shehata, Mostafa A. Hammam, Rasha S. Enany, Sally M. El-Hefnawy, Shimaa Abdelsattar
Uncoupling protein 2 and dynamin-related protein 1 mRNA expressions as genetic markers for plaque psoriasis
IJD 2022; 61(6):710-717Bruno Halioua, Clara Chelli, Laurent Misery, Jonathan Taieb, Charles Taieb
Sleep disorders and psoriasis: An update
Acta Derm Venereol. 2022 Apr 27;102:adv00699Michael S. Garshick, Kamelia Drenkova, Tessa J. Barrett, Florencia Schlamp, Edward A. Fisher, Stuart Katz, Sanja Jelic, Andrea L. Neimann, Jose U. Scher, James Krueger, Jeffrey S. Berger
A randomized open-label clinical trial of lipid-lowering therapy in psoriasis to reduce vascular endothelial inflammation
J Invest Dermatol. 2022 Jun;142(6):1749-1752Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang, Yu-Huei Huang
Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis
Ther Adv Chronic Dis. 2022 May 2;13:20406223221091188.S Chabra, B J Gill, G Gallo, D Zhu, C Pitou, C D Payne, A Accioly, L Puig
Ixekizumab citrate-free formulation: Results from two clinical trials
Adv Ther. 2022 Apr 21;1-11V Di Lernia, L Macca, L Peterle, Y Ingrasciotta, G Trifirò, C Guarneri
Efficacy of systemic biologic drugs in pediatric psoriasis: Evidence from five selected randomized clinical trials
Front Pharmacol. 2022 Apr 5;13:847308E Sahin, M Hawro, K Weller, R Sabat, S Philipp, G Kokolakis, D Christou, M Metz, M Maurer, T Hawro
Prevalence and factors associated with sleep disturbance in adult patients with psoriasis
J Eur Acad Dermatol Venereol. 2022 May;36(5):688-697A Norden, S Rekhtman, A Strunk, A Garg
Risk of psoriasis according to body mass index: A retrospective cohort analysis
J Am Acad Dermatol. 2022 May;86(5):1020-1026C Choonhakarn, S Chaowattanapanit, N Julanon, P Limpawattana
Comparison of the clinical efficacy of subcutaneous vs. oral administration of methotrexate in patients with psoriasis vulgaris: A randomized controlled trial
Clin Exp Dermatol. 2022 May;47(5):942-948A B Gottlieb, A Deodhar, I B Mcinnes, X Baraliakos, K Reich, S Schreiber, W Bao, K Marfo, H B Richards, L Pricop, A Shete, V Trivedi, D Keefe, C C Papavassilis, P Jagiello, P Papanastasiou, P J Mease, M Lebwohl
Long-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance data
Acta Derm Venereol. 2022 Apr 27;102:adv00698K Reich, D Thaçi, G Stingl, J S Andersen, L C Hiort, M O Lexner, D Winkler, C Paul
Safety of brodalumab in plaque psoriasis: Integrated pooled data from five clinical trials
Acta Derm Venereol. 2022 Mar 28;102:adv00683V Viswanath, P Joshi, P Lawate, D Tare, D Dhoot, N Mahadkar, H Barkate